modafinil has been researched along with methylphenidate in 140 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (2.86) | 18.2507 |
| 2000's | 30 (21.43) | 29.6817 |
| 2010's | 78 (55.71) | 24.3611 |
| 2020's | 28 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hajdukovic, R; Mitler, MM | 1 |
| Boer, C; De Séréville, JE; Duteil, J; Rambert, FA | 1 |
| Hou, Y; Jouvet, M; Lin, JS | 1 |
| Grebow, PE; King, SP; Laughton, WB; McCormick, GC; Wong, YN | 1 |
| Jasinski, DR | 1 |
| Arora, S; Hellriegel, ET; Nelson, M; Robertson, P | 1 |
| Christodoulou, C; Krupp, LB | 1 |
| Hayduk, R; Kovacevic-Ristanovic, R; Schwartz, JR; Thorpy, MJ | 1 |
| Hall, SS | 1 |
| Feldman, NT; Fry, JM; Harsh, J; Schwartz, JR | 1 |
| Boutrel, B; Koob, GF | 1 |
| Schwartz, JR | 1 |
| Biederman, J | 1 |
| Elsner, F; Radbruch, L; Reineke-Bracke, H | 1 |
| Eagle, DM; Goodchild, HL; Robbins, TW; Tufft, MR | 1 |
| Thorpy, M | 1 |
| Akhondzadeh, S; Amiri, S; Kahbazi, M; Mohammadi, M; Mohammadi, MR; Nouroozinejad, GH | 1 |
| Ishizuka, T; Murakami, M; Yamatodani, A | 1 |
| DeVane, CL; Donovan, JL; Gibson, BB; Jiang, Y; Markowitz, JS; Wang, JS; Zhu, HJ | 1 |
| Ng, B | 2 |
| Husain, AM; Peterson, PC | 1 |
| Fillmorex, MT; Hays, LR; Rush, CR; Vansickel, AR | 1 |
| Dodds, C; Manly, T; Müller, U | 1 |
| McNeil, C | 1 |
| Fischer, J; Gibbons, JA; Isdahl, WM; Ramsey, CS; Werchan, PM | 1 |
| Alici, Y; Breitbart, W | 1 |
| Guerrero, IL; Sander, C | 1 |
| Masand, PS; Pae, CU; Patkar, AA | 1 |
| Elvira, Jde L; Ramaekers, JG; Theunissen, EL; van den Bergh, D | 1 |
| Stix, G | 1 |
| Hazin, R; Iqbal, M; Khan, F | 1 |
| Grabowski, J; Herin, DV; Rush, CR | 1 |
| Baumann, F; Bublak, P; Dodds, CM; Finke, K; Manly, T; Müller, U; Regenthal, R | 1 |
| Hu, TW; Lang, HC; Scheffler, RM | 1 |
| Heuser, I; Laisney, O; Repantis, D; Schlattmann, P | 1 |
| Ali, M; Auger, RR; Morgenthaler, TI; Slocumb, NL | 1 |
| Burris, H; Cohen, RB; Danaee, H; Dees, EC; Ecsedy, J; Eton, O; Fingert, H; Galvin, K; Infante, JR; Jones, S; Lee, Y; Liu, H; Manfredi, M; O'Neil, BH; Stringer, B; von Mehren, M | 1 |
| Goodman, R | 1 |
| Elsner, F; Krumm, N; Peuckmann, V; Radbruch, L; Trottenberg, P | 1 |
| Banjo, OC; Nadler, R; Reiner, PB | 1 |
| Gall, CM; Lynch, G; Palmer, LC | 1 |
| Centeno, C; Portela, MA; Rubiales, AS | 1 |
| Franke, AG; Huss, M; Konrad, A; Lieb, K | 1 |
| Baier, AR; Coons, EE; Fingesten, A; Ockert, DM; Volpicelli, JR | 1 |
| Quinnell, TG; Smith, IE | 1 |
| Collins, R; Etzel, CJ; Gehring, K; Groves, MD; Meyers, CA; Patwardhan, SY; Wefel, JS | 1 |
| Howland, RH | 1 |
| Camenzind, M | 1 |
| Bennett-Back, O; Goez, HR; Nevo, N; Scott, O; Zelnik, N | 1 |
| Santamaria-Cano, J | 1 |
| Levin, FR; Mariani, JJ | 1 |
| Dell'Osso, B; Ketter, TA | 1 |
| Caflisch, C; Herdener, M; Oppliger, R; Stohler, R | 1 |
| Buckley, NW; France, CP; Gosden, J; Hackett, D; Heal, DJ; Slater, N | 1 |
| Aagaard, L; Hansen, EH | 1 |
| Capellà, D; Castells, X; Farre, M; Pérez-Mañá, C; Torrens, M | 1 |
| Bachman, DL; Drye, LT; Herrmann, N; Lanctôt, KL; Mintzer, JE; Rosenberg, PB; Scherer, RW | 1 |
| Brammer, RJ; Gosden, J; Hackett, D; Heal, DJ; Kulkarni, RS; Rowley, HL | 1 |
| Anagnostaras, SG; Sage, JR; Shuman, T; Wood, S | 1 |
| Bagot, KS; Kaminer, Y | 1 |
| Bahadori, R; Bates, N; Benepal, T; Blackhall, F; Dutton, S; Fife, K; O'Brien, M; Spathis, A; Stone, P; Wee, B; Wharton, R | 1 |
| Barton, D; Loprinzi, CL; Ruddy, KJ | 1 |
| Danysz, W; Flik, G; Hauber, W; Russ, H; Sommer, S; Valastro, B | 1 |
| Are, M; Baker, KS; Demark-Wahnefried, W; Denlinger, CS; Freedman-Cass, DA; Friedman, DL; Goldman, M; Jones, L; King, A; Ku, GH; Kvale, E; Langbaum, TS; Leonardi-Warren, K; Ligibel, JA; McCabe, MS; McMillian, NR; Melisko, M; Montoya, JG; Mooney, K; Morgan, MA; Moslehi, JJ; O'Connor, T; Overholser, L; Paskett, ED; Raza, M; Syrjala, KL; Urba, SG; Wakabayashi, MT; Zee, P | 1 |
| Fond, G; MacGregor, A; Micoulaud-Franchi, JA | 1 |
| Borghgraef, C; Delvaux, N; Etienne, AM; Libert, Y; Razavi, D; Reynaert, C | 1 |
| Castellino, SM; Lange, BJ; Ullrich, NJ; Whelen, MJ | 1 |
| Aagaard, L; Hansen, EH; Warrer, P | 1 |
| Bard, I; Jackson, J; Singh, I | 1 |
| Brown, PD; Day, J; Gehring, K; Grant, R; Grosshans, D; Li, J; Taphoorn, M; Zienius, K | 1 |
| Cuhls, H; Minton, O; Mücke, M; Peuckmann-Post, V; Radbruch, L; Stone, P | 1 |
| Henning, M; Hussainy, S; Jensen, M; Ram, SS; Russell, B | 1 |
| Abbar, M; Brunel, L; Fond, G; Lancon, C; Lopez, R; Macgregor, A; Micoulaud-Franchi, JA; Miot, S; Repantis, D; Richieri, R | 1 |
| Morein-Zamir, S; Sahakian, BJ | 1 |
| Baker, LE; Quisenberry, AJ | 1 |
| Huang, J; Qiu, F; Qu, D; Yu, X; Zhang, Z; Zhao, J | 1 |
| Bickel, WK; Quisenberry, AJ; Snider, SE | 1 |
| Bisagno, V; González, B; Urbano, FJ | 1 |
| Bassett, D; Boyce, P; Byrow, Y; Hopwood, M; Lyndon, W; Malhi, GS; Mulder, R; Murray, G; Porter, R; Singh, A | 1 |
| Dance, A | 1 |
| Hauber, W; Roschlau, C; Votteler, A | 1 |
| Atkins, C; Wilson, AM | 1 |
| Brühl, AB; Fox, C; O'Brien, JT; Piercy, T; Rowe, JB; Sahakian, BJ; Savulich, G; Suckling, J | 1 |
| Connemann, BJ; Gahr, M; Schönfeldt-Lecuona, C; Zeiss, R | 1 |
| Agricola, A; Balló, HE; Frank, B; Franke, AG; Gerdes, C; Gorbulev, S; Gränsmark, P; Lieb, K; Rommel, T; Ruckes, C; Schühle, K; Sebastian, A; Tüscher, O | 1 |
| Lazenka, MF; Negus, SS | 1 |
| Alfano, CM; Heckler, C; Kleckner, AS; Kleckner, IR; Leach, CR; Miller, SM; Mohr, D; Mustian, KM; Palesh, OG; Peppone, LJ; Piper, BF; Scarpato, J; Smith, T; Sprod, LK | 1 |
| Henning, M; Hussainy, S; Jensen, M; Ram, SS; Russell, B; Stewart, K | 1 |
| Borgwardt, S; Dolder, PC; Liechti, ME; Müller, F; Schmid, Y; Schmidt, A; Zanchi, D | 1 |
| Borgwardt, SJ; Dolder, PC; Liechti, ME; Müller, F; Schmid, Y | 1 |
| Jerrell, JM; Kennedy, SH; Lam, RW; Lee, Y; McIntyre, RS; Peters, EM; Rong, C; Rosenblat, JD; Zhou, AJ | 1 |
| Arango-Lopez, C; Canellas-Dols, F; Delgado, C; Peraita-Adrados, R | 1 |
| Nourbakhsh, B; Revirajan, N; Waubant, E | 1 |
| Borgwardt, S; Dolder, PC; Egloff, L; Liechti, ME; Müller, F; Schmid, Y; Schmidt, A; Zanchi, D | 1 |
| Iglseder, B | 1 |
| Abraham, EH; Chan, S; Herrmann, N; Lanctôt, KL; Ruthirakuhan, MT | 1 |
| Casavant, MJ; Chounthirath, T; Hodges, NL; King, SA; Smith, GA; Spiller, HA | 1 |
| Locatelli, I; Lukić, P; Stuhec, M | 1 |
| Cameron, J; Harney, A; Jenner, L; Lee, NK | 1 |
| Giancola, JB; Keighron, JD; Lin, SC; Newman, AH; Scaglione, A; Tanda, G; Zanettini, C | 1 |
| Dietrich, J; Karschnia, P; Parsons, MW | 1 |
| Cao, J; Jordan, CJ; Newman, AH; Xi, ZX | 1 |
| Chrzanowski, Ł; Corvini, PF; Wilms, W; Woźniak-Karczewska, M | 1 |
| Cléophat-Jolicoeur, MIF; Dogba, MJ; Dossa, R; Gagnon, B; Miladi, N | 1 |
| Cepeda, MS; Kern, DM; Lovestone, S; Seabrook, GR | 1 |
| Dargan, PI; Hockenhull, J; Wood, DM | 1 |
| Dean, A | 1 |
| Ando, M; Daida, K; Hattori, N; Hayashida, A; Kanbayashi, T; Noda, K; Ogaki, K; Okuma, Y; Yokoyama, K | 1 |
| Bertoldi, AD; de Oliveira Cata Preta, B; Miranda, VIA | 1 |
| Alam, N; Chaudhary, K | 1 |
| Broe, A; Damkier, P | 1 |
| Chang, HA; Chen, TY; Chien, WC; Chung, CH; Kao, YC; Lin, CS; Lin, YC; Tsai, CS; Tzeng, NS | 1 |
| Bogan, RK; Thorpy, MJ | 1 |
| Bi, GH; Chun, LE; Coggiano, MA; Hiranita, T; Jordan, CJ; Katz, JL; Keighron, JD; Lopez, JP; Mereu, M; Newman, AH; Quarterman, JC; Tanda, G; Xi, ZX | 1 |
| Brink, P; Nielsen, J; Rohde, C; Østergaard, SD | 1 |
| Brandão, ER; De Castro, BP | 1 |
| Górska, M; Rozenek, EB; Waszkiewicz, N; Wilczyńska, K | 1 |
| Arcadepani, FB; Bisaga, A; Fidalgo, TM; Gerra, G; Levin, FR; Tardelli, VS | 1 |
| Gage, SH; Jones, A; Montgomery, C; Roberts, CA; Sumnall, H | 1 |
| Bai, Z; Charach, A; Chojecki, D; Eagles, C; Elliott, J; Hossain, A; Hsieh, SC; Husereau, D; Johnston, A; Kelly, SE; Mamdani, M; Skidmore, B; Tsakonas, E; Wells, GA | 1 |
| Bovy, L; Dresler, M; Kühn, S; Ohla, K; Repantis, D | 1 |
| Curley, L; Henning, M; Hussainy, S; Kirkpatrick, C; Ram, SS; Russell, B; Scahill, S; Stewart, K | 1 |
| Aljarallah, S; Auvray, C; Cordano, C; Creasman, J; Jin, C; Krysko, K; Manguinao, M; McCulloch, C; Morris, B; Mowry, E; Nourbakhsh, B; Revirajan, N; Rutatangwa, A; Waubant, E | 1 |
| Bourdette, D | 1 |
| Chamula, K; Frenkel, S; Saini, B; Sivam, S; Swieca, J | 1 |
| Adam, LC; Dresler, M; Konrad, BN; Kühn, S; Repantis, D | 1 |
| Boldt, G; Bruera, E; Chiu, L; Chow, R; Lock, M; Prsic, E; Sanatani, M | 1 |
| Arillotta, D; Catalani, V; Corkery, JM; Fergus, S; Guirguis, A; Napoletano, F; Schifano, F; Sharif, S; Vento, A | 1 |
| Becker, M; Dresler, M; Kühn, S; Repantis, D | 1 |
| Böker, KO; Di Fazio, P; Jäckle, K; Lehmann, W; Schilling, AF; Wagener, N; Weiser, L | 1 |
| Brown, PD; Day, J; Gehring, K; Grosshans, D; Kirkman, MA; Li, J; Taphoorn, M; Zienius, K | 1 |
| Bang Madsen, K; Bergink, V; Dreier, JW; Groth, JB; Hove Thomsen, P; Kildegaard, H; Larsson, H; Liu, X; Momen, N; Munk-Olsen, T; Newcorn, JH; Robakis, TK | 1 |
| Fukumoto, S; Higashi, T; Imanari, E; Kosaka, H; Tomari, S | 1 |
| Bossaerts, P; Bowman, E; Coghill, D; Murawski, C | 1 |
| Adapa, R; Alnagger, NLN; Bahri, MA; Bonhomme, V; Cardone, P; Carhart-Harris, RL; de Araujo, DB; Demertzi, A; Golkowski, D; Hansen, JY; Ilg, R; Jaquet, O; Jordan, D; Luppi, AI; Manktelow, AE; Menon, DK; Misic, B; Naci, L; Owen, AM; Peattie, ARD; Ranft, A; Roseman, L; Sensi, SL; Stamatakis, EA; Timmermann, C; Vanhaudenhuyse, A | 1 |
50 review(s) available for modafinil and methylphenidate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fatigue in multiple sclerosis.
Topics: Amantadine; Autoimmune Diseases; Benzhydryl Compounds; Brain; Case Management; Central Nervous System Stimulants; Combined Modality Therapy; Cross-Over Studies; Depression; Double-Blind Method; Fatigue; Hot Temperature; Humans; Hypothalamus; Methylphenidate; Modafinil; Multiple Sclerosis; Patient Care Team; Pemoline; Physical Therapy Modalities; Pilot Projects; Randomized Controlled Trials as Topic; Self-Assessment; Severity of Illness Index; Tomography, Emission-Computed | 2001 |
What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications.
Topics: Amphetamine; Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Cocaine; Dopamine Uptake Inhibitors; Humans; Methylphenidate; Modafinil; Narcolepsy; Nicotine; Sleep; Wakefulness | 2004 |
Therapeutic advances in narcolepsy.
Topics: Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Humans; Immunotherapy; Methylphenidate; Modafinil; Narcolepsy; Quality of Life; Selective Serotonin Reuptake Inhibitors; Selegiline; Sodium Oxybate | 2007 |
Pediatric narcolepsy.
Topics: Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Child; Dextroamphetamine; Ghrelin; Hallucinations; Humans; Intracellular Signaling Peptides and Proteins; Leptin; Methylphenidate; Modafinil; Narcolepsy; Neuropeptides; Orexins; Polysomnography; Randomized Controlled Trials as Topic; Sleep, REM; Sodium Oxybate | 2008 |
Pharmacologic treatment options for cancer-related fatigue: current state of clinical research.
Topics: Antidepressive Agents; Benzhydryl Compounds; Central Nervous System Stimulants; Cholinesterase Inhibitors; Fatigue; Humans; Methylphenidate; Modafinil; Neoplasms | 2008 |
[Falling sleep inopportunely: treatment of narcolepsy].
Topics: Adolescent; Adult; Amphetamines; Antidepressive Agents; Benzhydryl Compounds; Central Nervous System Stimulants; Child; Diagnosis, Differential; Drug Therapy, Combination; Humans; Methylphenidate; Modafinil; Narcolepsy; Prevalence; Psychotherapy | 2008 |
Narcolepsy: clinical decision making for the primary care physician.
Topics: Benzhydryl Compounds; Biomarkers; Cataplexy; Central Nervous System Stimulants; Decision Making; Diagnosis, Differential; Drug Approval; Hallucinations; Humans; Intracellular Signaling Peptides and Proteins; Life Style; Methylphenidate; Modafinil; Narcolepsy; Neuropeptides; Orexins; Physicians, Family; Polysomnography; Primary Health Care; Quality of Life; Respiration; Risk Factors; Sleep Paralysis; Sleep Stages; Sodium Oxybate; United States; United States Food and Drug Administration | 2009 |
Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies.
Topics: Animals; Behavior Therapy; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Clinical Trials as Topic; Cognition; Dextroamphetamine; Humans; Levodopa; Methylphenidate; Modafinil; Substance-Related Disorders | 2010 |
Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review.
Topics: Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Cognition; Emotions; Humans; Methylphenidate; Modafinil; Motivation | 2010 |
Pharmacological treatments for fatigue associated with palliative care.
Topics: Adult; Amantadine; Benzhydryl Compounds; Central Nervous System Stimulants; Fatigue; Humans; Kidney Failure, Chronic; Methylphenidate; Modafinil; Multiple Sclerosis; Neoplasms; Palliative Care; Pemoline; Randomized Controlled Trials as Topic | 2010 |
The likelihood of cognitive enhancement.
Topics: Animals; Benzhydryl Compounds; Cognition; Humans; Long-Term Potentiation; Memory; Methylphenidate; Modafinil; Models, Neurological; Models, Psychological; Nootropic Agents; Translational Research, Biomedical | 2011 |
The use of psychostimulants in cancer patients.
Topics: Adult; Antineoplastic Agents; Asthenia; Benzhydryl Compounds; Central Nervous System Stimulants; Child; Depression; Fatigue; Female; Humans; Male; Methylphenidate; Modafinil; Neoplasms; Palliative Care; Survivors | 2011 |
[Stimulant and non-stimulant medication in current and future therapy for ADHD].
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Central Nervous System Stimulants; Child; Dextroamphetamine; Fatty Acids, Omega-3; Guanfacine; Histamine Agonists; Humans; Isoxazoles; Lisdexamfetamine Dimesylate; Memantine; Methylphenidate; Modafinil; Off-Label Use; Propylamines; Pyridines; Pyrrolidines; Receptors, AMPA | 2012 |
[Diagnostic and therapeutic update in narcolepsy].
Topics: Adolescent; Adult; Age of Onset; Animals; Autoimmune Diseases; Benzhydryl Compounds; Cataplexy; Child; Clomipramine; Cyclohexanols; Delayed Diagnosis; Disease Models, Animal; Dogs; Genetic Predisposition to Disease; Histamine Agonists; HLA-DQ Antigens; HLA-DQ beta-Chains; Humans; Hypothalamus; Immunoglobulins, Intravenous; Intracellular Signaling Peptides and Proteins; Methylphenidate; Modafinil; Narcolepsy; Neuropeptides; Orexins; Polysomnography; Receptors, Antigen, T-Cell; Sodium Oxybate; Venlafaxine Hydrochloride | 2012 |
Psychostimulant treatment of cocaine dependence.
Topics: Amphetamines; Animals; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Clinical Trials as Topic; Cocaine; Cocaine-Related Disorders; Combined Modality Therapy; Dopamine Agents; Humans; Methylphenidate; Modafinil; Placebos; Rats; Reinforcement, Psychology; United States | 2012 |
Use of adjunctive stimulants in adult bipolar depression.
Topics: Adult; Antipsychotic Agents; Benzhydryl Compounds; Bipolar Disorder; Central Nervous System Stimulants; Drug Therapy, Combination; Humans; Methylphenidate; Modafinil | 2013 |
[Treating cocaine addiction].
Topics: Acetylcysteine; Alcohol Deterrents; Baclofen; Benzhydryl Compounds; Central Nervous System Stimulants; Cocaine-Related Disorders; Cross-Sectional Studies; Diagnosis, Dual (Psychiatry); Disulfiram; Free Radical Scavengers; Humans; Mental Disorders; Methylphenidate; Modafinil; Muscle Relaxants, Central; Psychotherapy; Switzerland | 2012 |
Efficacy of psychostimulant drugs for amphetamine abuse or dependence.
Topics: Amphetamine-Related Disorders; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Humans; Methylphenidate; Modafinil; Randomized Controlled Trials as Topic | 2013 |
Psychostimulants and cognition: a continuum of behavioral and cognitive activation.
Topics: Animals; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Cocaine; Cognition; Humans; Methamphetamine; Methylphenidate; Modafinil | 2014 |
Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review.
Topics: Adolescent; Adult; Amphetamine; Attention; Benzhydryl Compounds; Central Nervous System Stimulants; Cognition; Humans; Mental Recall; Methylphenidate; Modafinil; Nootropic Agents; Problem Solving; Young Adult | 2014 |
[Treatment of cognitive impairments in oncology: a review of longitudinal controlled studies].
Topics: Adult; Benzhydryl Compounds; Case-Control Studies; Central Nervous System Stimulants; Cognition; Cognition Disorders; Darbepoetin alfa; Donepezil; Erythropoietin; Estradiol; Executive Function; Female; Humans; Indans; Longitudinal Studies; Male; Meditation; Methylphenidate; Modafinil; Neoplasms; Piperidines | 2014 |
Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors.
Topics: Adolescent; Adult; Age Factors; Antimetabolites, Antineoplastic; Attention; Benzhydryl Compounds; Brain Neoplasms; Central Nervous System Stimulants; Child; Child, Preschool; Cognitive Dysfunction; Comorbidity; Cranial Irradiation; Donepezil; Early Intervention, Educational; Education, Special; Head and Neck Neoplasms; Human Growth Hormone; Humans; Indans; Infant; Injections, Spinal; Memory, Short-Term; Methotrexate; Methylphenidate; Modafinil; Neoplasms; Neurosurgical Procedures; Nootropic Agents; Patient Education as Topic; Piperidines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Psychomotor Performance; Quality of Life; Radiotherapy Dosage; Risk Factors; Severity of Illness Index; Sex Factors; Survivors; Thinking; Wakefulness-Promoting Agents; Young Adult | 2014 |
Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation.
Topics: Adult; Benzhydryl Compounds; Cognition Disorders; Cranial Irradiation; Donepezil; Humans; Indans; Memantine; Methylphenidate; Modafinil; Nootropic Agents; Piperidines; Randomized Controlled Trials as Topic | 2014 |
Pharmacological treatments for fatigue associated with palliative care.
Topics: Adult; Amantadine; Benzhydryl Compounds; Carnitine; Central Nervous System Stimulants; Chronic Disease; Fatigue; Humans; Kidney Failure, Chronic; Methylphenidate; Modafinil; Multiple Sclerosis; Neoplasms; Palliative Care; Pemoline; Randomized Controlled Trials as Topic | 2015 |
Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review.
Topics: Adult; Attention; Benzhydryl Compounds; Central Nervous System Stimulants; Cognition; Humans; Levodopa; Male; Memory, Episodic; Methylphenidate; Modafinil; Nicotine; Nootropic Agents | 2015 |
Psychotropic drugs for the management of cancer-related fatigue: a systematic review and meta-analysis.
Topics: Benzhydryl Compounds; Fatigue; Humans; Methylphenidate; Modafinil; Neoplasms; Psychotropic Drugs | 2016 |
Does impulsivity change rate dependently following stimulant administration? A translational selective review and re-analysis.
Topics: Amphetamine; Benzhydryl Compounds; Central Nervous System Stimulants; Clinical Trials as Topic; Humans; Impulsive Behavior; Methylphenidate; Modafinil | 2016 |
Cognitive enhancers versus addictive psychostimulants: The good and bad side of dopamine on prefrontal cortical circuits.
Topics: Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Cocaine; Dopamine; Humans; Methamphetamine; Methylphenidate; Modafinil; Nootropic Agents; Prefrontal Cortex; Substance-Related Disorders | 2016 |
Stimulants for depression: On the up and up?
Topics: Amphetamine; Antidepressive Agents; Benzhydryl Compounds; Bipolar Disorder; Central Nervous System Stimulants; Depression; Depressive Disorder, Major; Dextroamphetamine; Drug Therapy, Combination; Humans; Methylphenidate; Modafinil; Randomized Controlled Trials as Topic | 2016 |
Managing fatigue in sarcoidosis - A systematic review of the evidence.
Topics: Adalimumab; Antirheumatic Agents; Benzhydryl Compounds; Central Nervous System Stimulants; Exercise Therapy; Fatigue; Humans; Infliximab; Methylphenidate; Modafinil; Oligopeptides; Sarcoidosis; Tumor Necrosis Factor-alpha | 2017 |
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis.
Topics: Benzhydryl Compounds; Central Nervous System Stimulants; Cognitive Behavioral Therapy; Dexmethylphenidate Hydrochloride; Dextroamphetamine; Exercise Therapy; Fatigue; Glucocorticoids; Humans; Methylphenidate; Methylprednisolone; Modafinil; Neoplasms; Paroxetine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Wakefulness-Promoting Agents | 2017 |
The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis.
Topics: Benzhydryl Compounds; Central Nervous System Stimulants; Depressive Disorder, Major; Dextroamphetamine; Humans; Methylphenidate; Modafinil; Psychotropic Drugs; Treatment Outcome | 2017 |
[Doping for the brain].
Topics: Aged; Amphetamines; Brain; Cognitive Aging; Dietary Supplements; Humans; Illicit Drugs; Methylphenidate; Modafinil; Nootropic Agents; Plant Preparations; Prescription Drugs; Psychotropic Drugs; Substance-Related Disorders | 2018 |
Pharmacological interventions for apathy in Alzheimer's disease.
Topics: Alanine; Alzheimer Disease; Antidepressive Agents; Apathy; Azepines; Benzhydryl Compounds; Biphenyl Compounds; Central Nervous System Stimulants; Cholinesterase Inhibitors; Humans; Methylphenidate; Modafinil; Randomized Controlled Trials as Topic; Sulfonamides; Valproic Acid | 2018 |
Efficacy, Acceptability, and Tolerability of Lisdexamfetamine, Mixed Amphetamine Salts, Methylphenidate, and Modafinil in the Treatment of Attention-Deficit Hyperactivity Disorder in Adults: A Systematic Review and Meta-analysis.
Topics: Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Double-Blind Method; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Modafinil; Salts; Treatment Outcome | 2019 |
Pharmacotherapy for amphetamine dependence: A systematic review.
Topics: Amphetamine; Amphetamine-Related Disorders; Dextroamphetamine; Humans; Medication Adherence; Methylphenidate; Modafinil; Naltrexone; Randomized Controlled Trials as Topic | 2018 |
Pharmacologic management of cognitive impairment induced by cancer therapy.
Topics: Antineoplastic Agents; Central Nervous System Stimulants; Cholinesterase Inhibitors; Cognitive Dysfunction; Donepezil; Erythropoietin; Forecasting; Humans; Methylphenidate; Modafinil; Neoplasms; Radiotherapy | 2019 |
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.
Topics: Analgesics, Opioid; Buprenorphine; Central Nervous System Stimulants; Cocaine-Related Disorders; Dextroamphetamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Development; Humans; Methadone; Methylphenidate; Modafinil; Nicotinic Agonists; Opiate Substitution Treatment; Opioid-Related Disorders; Oxalates; Piperazines; Receptors, Opioid, mu; Tobacco Use Disorder; Tropanes; Varenicline | 2019 |
Nootropic drugs: Methylphenidate, modafinil and piracetam - Population use trends, occurrence in the environment, ecotoxicity and removal methods - A review.
Topics: Attention Deficit Disorder with Hyperactivity; Brain; Environmental Pollutants; Humans; Memory; Methylphenidate; Modafinil; Nootropic Agents; Piracetam; Wastewater | 2019 |
Psychostimulants for cancer-related cognitive impairment in adult cancer survivors: a systematic review and meta-analysis.
Topics: Adult; Cancer Survivors; Central Nervous System Stimulants; Cognition; Cognitive Dysfunction; Humans; Methylphenidate; Modafinil; Neoplasms; Quality of Life; Randomized Controlled Trials as Topic | 2019 |
The holistic management of fatigue within palliative care.
Topics: Central Nervous System Stimulants; Chronic Disease; Cognitive Behavioral Therapy; Complementary Therapies; Exercise Therapy; Fatigue; Holistic Nursing; Hospice and Palliative Care Nursing; Humans; Methylphenidate; Modafinil; Neoplasms; Patient Education as Topic | 2019 |
Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications.
Topics: Adult; Cataplexy; Humans; Methylphenidate; Modafinil; Narcolepsy; Sodium Oxybate | 2020 |
In search of optimal psychoactivation: stimulants as cognitive performance enhancers.
Topics: Adult; Aged; Aged, 80 and over; Central Nervous System Stimulants; Cognition; Cognition Disorders; Female; Humans; Male; Methylphenidate; Middle Aged; Modafinil; Nootropic Agents; Psychotropic Drugs; Young Adult | 2019 |
Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.
Topics: Amphetamine; Central Nervous System Stimulants; Cocaine; Double-Blind Method; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Modafinil; Prescription Drugs; Randomized Controlled Trials as Topic; Substance-Related Disorders; Treatment Outcome | 2020 |
How effective are pharmaceuticals for cognitive enhancement in healthy adults? A series of meta-analyses of cognitive performance during acute administration of modafinil, methylphenidate and D-amphetamine.
Topics: Adult; Cognition; Dextroamphetamine; Drug Administration Schedule; Female; Healthy Volunteers; Humans; Male; Mental Recall; Methylphenidate; Modafinil; Nootropic Agents; Pharmaceutical Preparations | 2020 |
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bayes Theorem; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug-Related Side Effects and Adverse Reactions; Female; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Modafinil; Network Meta-Analysis; Quality of Life; Randomized Controlled Trials as Topic | 2020 |
Cancer-related fatigue-pharmacological interventions: systematic review and network meta-analysis.
Topics: Central Nervous System Stimulants; Fatigue; Humans; Methylphenidate; Modafinil; Neoplasms; Network Meta-Analysis; Paroxetine | 2023 |
Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals.
Topics: Brain; Central Nervous System Stimulants; Cognition; Humans; Methylphenidate; Modafinil; Nootropic Agents | 2022 |
Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation.
Topics: Adult; Brain Neoplasms; Cognition; Cognitive Dysfunction; Cranial Irradiation; Dementia; Donepezil; Fatigue; Humans; Memantine; Methylphenidate; Modafinil; Quality of Life | 2022 |
26 trial(s) available for modafinil and methylphenidate
| Article | Year |
|---|---|
Relative efficacy of drugs for the treatment of sleepiness in narcolepsy.
Topics: Adult; Arousal; Benzhydryl Compounds; Central Nervous System Stimulants; Codeine; Dextroamphetamine; Female; Humans; Male; Methylphenidate; Modafinil; Narcolepsy; Pemoline; Piperidines; Protriptyline; Reaction Time; Ritanserin; Sleep Stages; Sodium Oxybate; Viloxazine; Wakefulness | 1991 |
Single-dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteers.
Topics: Adolescent; Adrenergic Agents; Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind Method; Drug Interactions; Humans; Male; Methylphenidate; Middle Aged; Modafinil | 1998 |
An evaluation of the abuse potential of modafinil using methylphenidate as a reference.
Topics: Adult; Appetite; Arousal; Benzhydryl Compounds; Central Nervous System Stimulants; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male; Methylphenidate; Middle Aged; Modafinil; Risk Factors; Sleep; Substance-Related Disorders | 2000 |
Steady-state pharmacokinetics and tolerability of modafinil given alone or in combination with methylphenidate in healthy volunteers.
Topics: Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Middle Aged; Modafinil | 2001 |
Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: an open-label safety study assessing three strategies.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Central Nervous System Stimulants; Drug Administration Schedule; Female; Humans; Male; Methylphenidate; Middle Aged; Modafinil; Narcolepsy; Psychiatric Status Rating Scales; Treatment Outcome; Wakefulness | 2003 |
Efficacy and safety of modafinil for improving daytime wakefulness in patients treated previously with psychostimulants.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Female; Humans; Male; Methylphenidate; Middle Aged; Modafinil; Narcolepsy; Pemoline; Psychiatric Status Rating Scales; Treatment Outcome; Wakefulness | 2003 |
Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Child; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Methylphenidate; Modafinil; Neuroprotective Agents; Retrospective Studies; Severity of Illness Index | 2008 |
Effects of potential agonist-replacement therapies for stimulant dependence on inhibitory control in cocaine abusers.
Topics: Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Cues; Dose-Response Relationship, Drug; Female; Humans; Inhibition, Psychological; Male; Methylphenidate; Modafinil; Reaction Time | 2008 |
Effects of psychostimulants on alertness and spatial bias in healthy participants.
Topics: Adult; Analysis of Variance; Attention; Benzhydryl Compounds; Bias; Central Nervous System Stimulants; Double-Blind Method; Female; Functional Laterality; Humans; Male; Methylphenidate; Modafinil; Neuropsychological Tests; Photic Stimulation; Reaction Time; Space Perception; Young Adult | 2009 |
Comparing the stimulant effects of the H1-antagonist fexofenadine with 2 psychostimulants, modafinil and methylphenidate.
Topics: Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Methylphenidate; Modafinil; Psychomotor Performance; Reaction Time; Terfenadine; Young Adult | 2009 |
Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study.
Topics: Adult; Attention; Benzhydryl Compounds; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Methylphenidate; Modafinil; Photic Stimulation; Psychomotor Performance; Reaction Time; Visual Perception; Young Adult | 2010 |
Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Aurora Kinases; Benzazepines; Benzhydryl Compounds; Central Nervous System Stimulants; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Half-Life; Humans; Male; Maximum Tolerated Dose; Methylphenidate; Middle Aged; Modafinil; Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Young Adult | 2011 |
A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor.
Topics: Adult; Benzhydryl Compounds; Brain Neoplasms; Central Nervous System Stimulants; Cognition Disorders; Female; Follow-Up Studies; Glioma; Humans; Male; Methylphenidate; Middle Aged; Modafinil; Neoplasm Grading; Pilot Projects; Prognosis | 2012 |
Using the test of variables of attention to determine the effectiveness of modafinil in children with attention-deficit hyperactivity disorder (ADHD): a prospective methylphenidate-controlled trial.
Topics: Adolescent; Attention; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Case-Control Studies; Central Nervous System Stimulants; Child; Double-Blind Method; Female; Humans; Male; Methylphenidate; Modafinil; Prospective Studies; Treatment Outcome | 2012 |
Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apathy; Benzhydryl Compounds; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Methylphenidate; Modafinil; Neuropsychological Tests; Psychometrics | 2013 |
Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial.
Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Carcinoma, Non-Small-Cell Lung; Central Nervous System Stimulants; Double-Blind Method; Drug Administration Schedule; Fatigue; Female; Humans; Lung Neoplasms; Male; Methylphenidate; Middle Aged; Modafinil; Placebo Effect; Severity of Illness Index; Treatment Failure; United Kingdom; Wakefulness-Promoting Agents | 2014 |
Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: A double-blind, randomised controlled trial.
Topics: Adult; Analysis of Variance; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Cognition; Cross-Sectional Studies; Double-Blind Method; Female; Humans; Male; Methylphenidate; Middle Aged; Modafinil; Neuropsychological Tests; Retrospective Studies; Wakefulness-Promoting Agents | 2017 |
Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects.
Topics: Benzhydryl Compounds; Brain; Brain Mapping; Central Nervous System Stimulants; Cognition; Cross-Over Studies; Double-Blind Method; Emotions; Female; Hallucinogens; Healthy Volunteers; Humans; Image Processing, Computer-Assisted; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Methylphenidate; Modafinil; N-Methyl-3,4-methylenedioxyamphetamine; Neural Pathways; Oxygen; Psychometrics | 2017 |
Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects.
Topics: Adult; Arousal; Autonomic Nervous System; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind Method; Emotions; Facial Recognition; Female; Hallucinogens; Healthy Volunteers; Humans; Libido; Male; Methylphenidate; Modafinil; N-Methyl-3,4-methylenedioxyamphetamine; Sexual Behavior; Young Adult | 2018 |
Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
Topics: Amantadine; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind Method; Fatigue; Humans; Methylphenidate; Modafinil; Multiple Sclerosis; Research Design | 2018 |
Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing.
Topics: Adult; Brain; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind Method; Facial Expression; Facial Recognition; Fear; Female; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Methylphenidate; Modafinil; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Agents; Young Adult | 2018 |
Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson's Drug Discovery.
Topics: Adrenergic beta-Antagonists; Adult; Antiparkinson Agents; Cohort Studies; Databases, Factual; Drug Discovery; Female; Humans; Male; Methylphenidate; Modafinil; Parkinson Disease, Secondary; Product Surveillance, Postmarketing | 2019 |
Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine.
Topics: Adult; Attention; Caffeine; Central Nervous System Stimulants; Cognition; Double-Blind Method; Fatigue; Humans; Male; Methylphenidate; Modafinil; Nootropic Agents; Pilot Projects; Treatment Outcome; Young Adult | 2021 |
Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.
Topics: Adult; Amantadine; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Fatigue; Female; Humans; Male; Methylphenidate; Middle Aged; Modafinil; Multiple Sclerosis; Outcome Assessment, Health Care; Severity of Illness Index | 2021 |
Memory enhancement with stimulants: Differential neural effects of methylphenidate, modafinil, and caffeine. A pilot study.
Topics: Adult; Caffeine; Central Nervous System Stimulants; Double-Blind Method; Humans; Magnetic Resonance Imaging; Methylphenidate; Modafinil; Pilot Projects | 2021 |
Cognitive enhancement: Effects of methylphenidate, modafinil, and caffeine on latent memory and resting state functional connectivity in healthy adults.
Topics: Adult; Brain; Brain Mapping; Caffeine; Central Nervous System Stimulants; Cognition; Double-Blind Method; Humans; Magnetic Resonance Imaging; Male; Methylphenidate; Modafinil; Neural Pathways | 2022 |
64 other study(ies) available for modafinil and methylphenidate
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Lack of pre-synaptic dopaminergic involvement in modafinil activity in anaesthetized mice: in vivo voltammetry studies.
Topics: alpha-Methyltyrosine; Anesthesia; Animals; Benzhydryl Compounds; Caudate Nucleus; Central Nervous System Stimulants; Dextroamphetamine; Dopamine; Electrophysiology; Male; Membrane Potentials; Methylphenidate; Methyltyrosines; Mice; Modafinil; Monoamine Oxidase Inhibitors; Pargyline; Receptors, Presynaptic; Tyrosine 3-Monooxygenase | 1994 |
Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.
Topics: Amphetamine; Animals; Benzhydryl Compounds; Brain; Cats; Central Nervous System Stimulants; Double-Blind Method; Genes, fos; Immunohistochemistry; Male; Methylphenidate; Modafinil; Neurons; Organ Specificity; Proto-Oncogene Proteins c-fos; Wakefulness | 1996 |
The quest for a smart pill.
Topics: Alzheimer Disease; Animals; Behavior, Animal; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Cognition; Cognition Disorders; Humans; Memory; Memory Disorders; Methylphenidate; Modafinil; Technology, Pharmaceutical | 2003 |
Sleepiness versus sleeplessness: shift work and sleep disorders.
Topics: Amphetamines; Benzhydryl Compounds; Central Nervous System Stimulants; Circadian Rhythm; Diagnosis, Differential; Humans; Methylphenidate; Modafinil; Primary Health Care; Psychiatric Status Rating Scales; Psychological Tests; Sleep; Sleep Disorders, Circadian Rhythm; Sleep Initiation and Maintenance Disorders; Work Schedule Tolerance | 2004 |
Pharmacologic management of daytime sleepiness.
Topics: Amphetamines; Benzhydryl Compounds; Central Nervous System Stimulants; Disorders of Excessive Somnolence; Follow-Up Studies; Humans; Methylphenidate; Modafinil; Patient Care Planning; Pemoline; Practice Patterns, Physicians' | 2004 |
Introduction: new developments in the treatment of attention-deficit/hyperactivity disorder.
Topics: Administration, Cutaneous; Adolescent; Adrenergic alpha-Agonists; Adult; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Central Nervous System Stimulants; Child; Guanfacine; Humans; Methylphenidate; Modafinil; Tablets | 2006 |
Treatment of fatigue: modafinil, methylphenidate, and goals of care.
Topics: Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Fatigue; Female; Germany; Humans; Melanoma; Methylphenidate; Modafinil; Palliative Care | 2006 |
Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Benzhydryl Compounds; Central Nervous System Stimulants; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Flupenthixol; Impulsive Behavior; Inhibition, Psychological; Male; Methylphenidate; Modafinil; Psychomotor Performance; Rats; Reaction Time; Receptors, Dopamine | 2007 |
Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats.
Topics: Animals; Benzhydryl Compounds; Central Nervous System; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Histamine; Male; Methylhistidines; Methylphenidate; Microdialysis; Modafinil; Motor Activity; Rats; Rats, Wistar; Time Factors; Wakefulness | 2008 |
Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein.
Topics: Adenosine Triphosphate; Amphetamine; Animals; Atomoxetine Hydrochloride; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Biological Transport; Central Nervous System Stimulants; Cyclosporins; Dose-Response Relationship, Drug; Doxorubicin; Isomerism; LLC-PK1 Cells; Methylphenidate; Modafinil; Propylamines; Reproducibility of Results; Rhodamine 123; Swine; Transfection | 2008 |
Methylphenidate and depression.
Topics: Antidepressive Agents; Benzhydryl Compounds; Central Nervous System Stimulants; Delayed-Action Preparations; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Humans; Methylphenidate; Modafinil; Psychiatric Status Rating Scales; Treatment Failure | 2008 |
No rest for fatigue researchers.
Topics: Activities of Daily Living; Anemia; Antineoplastic Agents; Benzhydryl Compounds; Central Nervous System Stimulants; Counseling; Darbepoetin alfa; Erythropoietin; Exercise; Fatigue; Hematinics; Humans; Meta-Analysis as Topic; Methylphenidate; Modafinil; Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Surveys and Questionnaires | 2008 |
Acceleration tolerance at night with acute fatigue and stimulants.
Topics: Acceleration; Adaptation, Physiological; Adult; Aerospace Medicine; Amphetamine; Analysis of Variance; Benzhydryl Compounds; Central Nervous System Stimulants; Circadian Rhythm; Cognition; Fatigue; Humans; Male; Methylphenidate; Modafinil; Pemoline; Physical Endurance; Sleep Deprivation | 2008 |
Is there a role for psychostimulants in old age depression and apathy?
Topics: Aged; Antidepressive Agents; Benzhydryl Compounds; Central Nervous System Stimulants; Depressive Disorder, Major; Dextroamphetamine; Drug Therapy, Combination; Humans; Methylphenidate; Modafinil; Motivation; Randomized Controlled Trials as Topic | 2009 |
Augmentation of dopaminergic agents for major depressive disorder.
Topics: Administration, Oral; Benzhydryl Compounds; Central Nervous System Stimulants; Combined Modality Therapy; Delayed-Action Preparations; Depressive Disorder, Major; Dopamine; Histamine; Humans; Hypothalamus; Intracellular Signaling Peptides and Proteins; Methylphenidate; Modafinil; Neuropeptides; Orexins; Randomized Controlled Trials as Topic; Treatment Outcome | 2009 |
Turbocharging the brain.
Topics: Alzheimer Disease; Benzhydryl Compounds; Brain; Central Nervous System Agents; Central Nervous System Stimulants; Cognition; Donepezil; Drug Industry; Humans; Indans; Legislation, Drug; Memory; Methylphenidate; Modafinil; Nootropic Agents; Piperidines; United States; United States Food and Drug Administration | 2009 |
The discrepancy in attention deficit hyperactivity disorder (ADHD) medications diffusion: 1994-2003--a global pharmaceutical data analysis.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Central Nervous System Stimulants; Drug Costs; Drug Industry; Economics; Healthcare Disparities; Humans; Methylphenidate; Modafinil; Propylamines; Time Factors; United States | 2010 |
Idiopathic hypersomnia: clinical features and response to treatment.
Topics: Actigraphy; Adult; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Dextroamphetamine; Female; Follow-Up Studies; Humans; Idiopathic Hypersomnia; Male; Methamphetamine; Methylphenidate; Modafinil; Pemoline; Polysomnography; Retrospective Studies; Sodium Oxybate; Treatment Outcome | 2009 |
Cognitive enhancement, cheating, and accomplishment.
Topics: Achievement; Benzhydryl Compounds; Central Nervous System Stimulants; Choice Behavior; Cognition; Deception; Dextroamphetamine; Humans; Methylphenidate; Modafinil; Nootropic Agents; Social Perception; Virtues | 2010 |
Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount.
Topics: Adult; Aged; Benzhydryl Compounds; Central Nervous System Stimulants; Cognition; Cognition Disorders; Drug Therapy; Drug Utilization; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Methylphenidate; Middle Aged; Modafinil; Nootropic Agents; Physicians; Piperazines; Practice Patterns, Physicians'; Purines; Safety; Sildenafil Citrate; Sulfones | 2010 |
A nonopioid procedure for outpatient opioid detoxification.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Clonidine; Drug Therapy, Combination; Female; GABA Modulators; Heroin Dependence; Humans; Lorazepam; Male; Methylphenidate; Middle Aged; Modafinil; New York; Opioid-Related Disorders; Outpatients; Selective Serotonin Reuptake Inhibitors; Substance Abuse Treatment Centers; Trazodone; Treatment Outcome; Young Adult | 2011 |
Narcolepsy, idiopathic hypersomnolence and related conditions.
Topics: Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Catalepsy; Central Nervous System Stimulants; Dextroamphetamine; Humans; Hypnotics and Sedatives; Idiopathic Hypersomnia; Life Style; Methylphenidate; Modafinil; Narcolepsy; Polysomnography; Selective Serotonin Reuptake Inhibitors; Sodium Oxybate; Treatment Outcome | 2011 |
The use of dopaminergic and stimulant drugs for the treatment of depression.
Topics: Amphetamines; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Depressive Disorder, Major; Dextroamphetamine; Dopamine; Dopamine Agents; Drug Therapy, Combination; Epinephrine; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Modafinil; Norepinephrine; Propylamines | 2012 |
[Brain doping. With smart pills becoming the perfect human being].
Topics: Achievement; Adolescent; Adult; Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Child; Doping in Sports; Energy Drinks; Female; Humans; Male; Methylphenidate; Modafinil; Motivation; Off-Label Use; Performance-Enhancing Substances; Social Adjustment; Social Conformity; Substance-Related Disorders; Switzerland; Young Adult | 2012 |
A preclinical evaluation of the discriminative and reinforcing properties of lisdexamfetamine in comparison to D-amfetamine, methylphenidate and modafinil.
Topics: Animals; Benzhydryl Compounds; Cocaine; Dextroamphetamine; Discrimination, Psychological; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Lisdexamfetamine Dimesylate; Methylphenidate; Modafinil; Rats; Reinforcement, Psychology; Self Administration | 2013 |
Adverse drug reaction labelling for atomoxetine, methylphenidate and modafinil: comparison of product information for oral formulations in Australia, Denmark and the United States.
Topics: Administration, Oral; Adverse Drug Reaction Reporting Systems; Atomoxetine Hydrochloride; Australia; Benzhydryl Compounds; Central Nervous System Stimulants; Denmark; Drug Industry; Drug Labeling; Humans; Methylphenidate; Modafinil; Propylamines; United States | 2013 |
Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats.
Topics: Animals; Behavior, Animal; Benzhydryl Compounds; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Microdialysis; Modafinil; Motor Activity; Prefrontal Cortex; Rats; Rats, Sprague-Dawley | 2014 |
Laying to rest psychostimulants for cancer-related fatigue?
Topics: Benzhydryl Compounds; Carcinoma, Non-Small-Cell Lung; Central Nervous System Stimulants; Fatigue; Female; Humans; Lung Neoplasms; Male; Methylphenidate; Modafinil | 2014 |
The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Choice Behavior; Corpus Striatum; Dextroamphetamine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Methylphenidate; Modafinil; Motivation; Neuropsychological Tests; Rats, Sprague-Dawley; Reinforcement Schedule | 2014 |
Survivorship: cognitive function, version 1.2014.
Topics: Adaptation, Psychological; Benzhydryl Compounds; Brain Neoplasms; Central Nervous System Stimulants; Cognition Disorders; Fatigue; Humans; Methylphenidate; Modafinil; Occupational Therapy; Pain Management; Quality of Life; Sleep Wake Disorders; Survival Rate; Treatment Outcome; Wakefulness-Promoting Agents | 2014 |
A preliminary study on cognitive enhancer consumption behaviors and motives of French Medicine and Pharmacology students.
Topics: Adolescent; Adult; Ascorbic Acid; Benzhydryl Compounds; Caffeine; Education, Medical; Female; France; Humans; Illicit Drugs; Male; Methamphetamine; Methylphenidate; Modafinil; Nootropic Agents; Pharmacology; Piracetam; Prevalence; Students, Health Occupations; Surveys and Questionnaires; Young Adult | 2014 |
Comparison of pregnancy and lactation labeling for attention-deficit hyperactivity disorder drugs marketed in Australia, the USA, Denmark, and the UK.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Australia; Benzhydryl Compounds; Central Nervous System Stimulants; Contraindications; Data Collection; Denmark; Drug Labeling; Female; Humans; Lactation; Methylphenidate; Modafinil; Pregnancy; Propylamines; United Kingdom; United States | 2014 |
Robust resilience and substantial interest: a survey of pharmacological cognitive enhancement among university students in the UK and Ireland.
Topics: Adolescent; Adult; Amphetamines; Benzhydryl Compounds; Female; Humans; Ireland; Male; Methylphenidate; Modafinil; Nootropic Agents; Sex Factors; Students; United Kingdom; Wakefulness-Promoting Agents | 2014 |
Prevalence of cognitive enhancer use among New Zealand tertiary students.
Topics: Adult; Amphetamines; Benzhydryl Compounds; Female; Humans; Male; Methylphenidate; Modafinil; Motivation; New Zealand; Nootropic Agents; Prevalence; Students; Substance-Related Disorders; Surveys and Questionnaires; Universities; Young Adult | 2016 |
Pharmacological cognitive enhancement: treatment of neuropsychiatric disorders and lifestyle use by healthy people.
Topics: Alzheimer Disease; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Humans; Life Style; Methylphenidate; Modafinil; Nootropic Agents | 2015 |
Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats.
Topics: Amphetamine; Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Cocaine; Dextroamphetamine; Dopamine; Dopamine Agents; Generalization, Psychological; Male; Methylphenidate; Modafinil; Nicotine; Piperazines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Wakefulness-Promoting Agents | 2015 |
Smart drugs: A dose of intelligence.
Topics: Aging; Amphetamines; Animals; Benzhydryl Compounds; Biomedical Enhancement; Caffeine; Child; Cognition; Dopamine; Healthy Volunteers; Humans; Intelligence; Intelligence Tests; Methylphenidate; Modafinil; Neurotransmitter Agents; Nicotine; Norepinephrine; Off-Label Use; Performance-Enhancing Substances; Prefrontal Cortex; Rats; Substance-Related Disorders; Video Games | 2016 |
Stimulant drug effects on touchscreen automated paired-associates learning (PAL) in rats.
Topics: Amphetamine; Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Conditioning, Operant; Dizocilpine Maleate; Dose-Response Relationship, Drug; Male; Methylphenidate; Modafinil; Nootropic Agents; Paired-Associate Learning; Rats; Wakefulness-Promoting Agents | 2016 |
Focusing the Neuroscience and Societal Implications of Cognitive Enhancers.
Topics: Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Cognition; Cognition Disorders; Ethics, Medical; Exercise; Humans; Life Style; Methylphenidate; Modafinil; Nootropic Agents; Patient Education as Topic; Video Games | 2017 |
Sensitivity of Quantitative Signal Detection in Regards to Pharmacological Neuroenhancement.
Topics: Adrenergic Uptake Inhibitors; Adverse Drug Reaction Reporting Systems; Atomoxetine Hydrochloride; Australia; Benzhydryl Compounds; Canada; Central Nervous System Stimulants; Drug-Related Side Effects and Adverse Reactions; Excitatory Amino Acid Antagonists; France; Germany; Humans; Italy; Memantine; Methylphenidate; Modafinil; Pharmacovigilance; Spain; Substance-Related Disorders; United Kingdom; United States; Wakefulness-Promoting Agents | 2017 |
Oral modafinil facilitates intracranial self-stimulation in rats: comparison with methylphenidate.
Topics: Administration, Oral; Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Male; Medial Forebrain Bundle; Methylphenidate; Modafinil; Rats; Rats, Sprague-Dawley; Self Administration; Self Stimulation; Time Factors; Wakefulness-Promoting Agents | 2017 |
Attitudes Toward Cognitive Enhancer Use Among New Zealand Tertiary Students.
Topics: Amphetamine; Benzhydryl Compounds; Central Nervous System Stimulants; Female; Health Knowledge, Attitudes, Practice; Humans; Intention; Male; Methylphenidate; Modafinil; New Zealand; Nootropic Agents; Off-Label Use; Prescription Drugs; Psychological Theory; Students; Surveys and Questionnaires; Universities; Young Adult | 2017 |
Narcolepsy-cataplexy and psychosis: a case study.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Female; Food Addiction; Hallucinations; Haloperidol; HLA-DQ beta-Chains; Humans; Learning Disabilities; Methylphenidate; Modafinil; Narcolepsy; Orexins; Pediatric Obesity; Polysomnography; Psychotic Disorders; Risperidone; Sleep Deprivation; Sleep Latency; Social Isolation; Sodium Oxybate; Suicidal Ideation | 2017 |
Pediatric ADHD Medication Exposures Reported to US Poison Control Centers.
Topics: Adolescent; Age Distribution; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Drug Misuse; Humans; Infant; Infant, Newborn; Medication Errors; Methylphenidate; Modafinil; Patient Admission; Poison Control Centers; Retrospective Studies; Suicide, Attempted; United States; Young Adult | 2018 |
Pharmacological classification of centrally acting drugs using EEG in freely moving rats: an old tool to identify new atypical dopamine uptake inhibitors.
Topics: Animals; Central Nervous System Agents; Cocaine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Discovery; Electroencephalography; Heroin; Ketamine; Male; Methylphenidate; Modafinil; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu | 2019 |
The Availability of Modafinil and Methylphenidate Purchased from the Internet in the United Kingdom Without a Prescription.
Topics: Adult; Central Nervous System Stimulants; Humans; Internet; Male; Methylphenidate; Modafinil; Prescription Drug Diversion; United Kingdom | 2020 |
Somnolence Preceded the Development of a Subthalamic Lesion in Neuromyelitis Optica Spectrum Disorder.
Topics: Aged; Central Nervous System Stimulants; Female; Humans; Japan; Magnetic Resonance Imaging; Methylphenidate; Modafinil; Narcolepsy; Neuromyelitis Optica; Sleepiness; Subthalamus; Treatment Outcome; Wakefulness-Promoting Agents | 2020 |
Psychostimulant Use for Neuroenhancement (Smart Drugs) among College Students in Brazil.
Topics: Brazil; Central Nervous System Stimulants; Cognition; Cross-Sectional Studies; Humans; Methylphenidate; Modafinil; Pharmaceutical Preparations; Piracetam; Students; Substance-Related Disorders; Universities | 2020 |
Repeated restraint stress potentiates methylphenidate and modafinil-induced behavioral sensitization in rats.
Topics: Adaptation, Psychological; Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Locomotion; Male; Methylphenidate; Modafinil; Motor Activity; Open Field Test; Rats, Sprague-Dawley; Reinforcement, Psychology; Restraint, Physical; Stress, Psychological; Time Factors | 2020 |
First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations.
Topics: Abnormalities, Drug-Induced; Adult; Central Nervous System Stimulants; Denmark; Female; Humans; Logistic Models; Methylphenidate; Modafinil; Pregnancy; Pregnancy Trimester, First; Product Surveillance, Postmarketing; Registries | 2020 |
Stimulants associated with reduced risk of hospitalization for motor vehicle accident injury in patients with obstructive sleep apnea-a nationwide cohort study.
Topics: Accidents, Traffic; Adult; Aged; Central Nervous System Stimulants; Databases, Factual; Female; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Methylphenidate; Middle Aged; Modafinil; Motor Vehicles; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sleep Apnea, Obstructive; Taiwan; Young Adult | 2020 |
Modafinil potentiates cocaine self-administration by a dopamine-independent mechanism: possible involvement of gap junctions.
Topics: Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Cocaine; Dopamine; Dose-Response Relationship, Drug; Gap Junctions; Methylphenidate; Modafinil; Rats; Rats, Sprague-Dawley | 2020 |
The use of stimulants in depression: Results from a self-controlled register study.
Topics: Adult; Amphetamine; Central Nervous System Stimulants; Denmark; Depression; Dextroamphetamine; Drug Prescriptions; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Modafinil; Registries; Suicide, Attempted | 2020 |
[Circulation of information on drugs and other substances to increase cognitive performance: a study of a Brazilian blog (2015-2017)].
Topics: Amphetamines; Blogging; Brazil; Central Nervous System Stimulants; Cognition; Humans; Information Dissemination; Medicalization; Methylphenidate; Modafinil; Nootropic Agents | 2020 |
Professionals' attitudes towards the use of cognitive enhancers in academic settings.
Topics: Adult; Aged; Attitude of Health Personnel; Central Nervous System Stimulants; Cognition; Dextroamphetamine; Female; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Male; Methylphenidate; Middle Aged; Modafinil; New Zealand; Prescription Drugs; Students; Surveys and Questionnaires; Universities; Young Adult | 2020 |
Are drugs for multiple sclerosis fatigue just placebos?
Topics: Amantadine; Double-Blind Method; Fatigue; Humans; Methylphenidate; Modafinil; Multiple Sclerosis; Pharmaceutical Preparations | 2021 |
Narcolepsy management in Australia: time to wake up.
Topics: Australia; Dextroamphetamine; Drug Costs; Health Expenditures; Health Services Accessibility; Humans; Methylphenidate; Modafinil; Narcolepsy; Polysomnography; Practice Guidelines as Topic; Prevalence; Randomized Controlled Trials as Topic; Sodium Oxybate; Treatment Outcome; Wakefulness-Promoting Agents | 2021 |
Psychostimulants Modafinil, Atomoxetine and Guanfacine Impair Bone Cell Differentiation and MSC Migration.
Topics: Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cell Differentiation; Central Nervous System Stimulants; Child; Guanfacine; Humans; Ligands; Methylphenidate; Modafinil; Nootropic Agents; Osteoprotegerin; Receptor Activator of Nuclear Factor-kappa B | 2022 |
In utero exposure to ADHD medication and long-term offspring outcomes.
Topics: Adult; Amphetamines; Attention Deficit Disorder with Hyperactivity; Child, Preschool; Clonidine; Cohort Studies; Denmark; Female; Gestational Age; Humans; Infant; Methylphenidate; Modafinil; Mothers; Neurodevelopmental Disorders; Pregnancy; Prenatal Exposure Delayed Effects; Registries | 2023 |
[Psychostimulants: An Overview].
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Modafinil | 2023 |
Not so smart? "Smart" drugs increase the level but decrease the quality of cognitive effort.
Topics: Cognition; Humans; Methylphenidate; Modafinil; Motivation; Plastic Surgery Procedures | 2023 |
In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.
Topics: Brain; Humans; Ketamine; Membrane Transport Proteins; Methylphenidate; Modafinil | 2023 |